In the current consolidation phase for pharma sector, investors should focus on winners for the long term. Cipla, with its leadership in inhalation, focus on green chemistry and potential deployment of cash savings for new growth drivers, warrants attention. We tell you why.
first published: Aug 6, 2021 07:40 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell
Live: Can Nifty claim new lifetime highs in December series? | Opening Bell
Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell
Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
